荷尔蒙避孕药对基线静脉/眼部症状的影响以及引起脑震荡的诱因
Ryan N Moran1, J Russell Guin2, Christian Roehmer3
1Department of Health Science, Athletic Training Research Laboratory, The University of Alabama, Tuscaloosa, Alabama, USA.
Orthopaedic journal of sports medicine
|August 19, 2024
概括
女性使用荷尔蒙避孕药 (HC) 与非使用者和男性相比,与增加脑震荡症状和更糟糕的恢复有关. 这凸显了在脑震荡评估和管理中考虑HC使用的必要性.
科学领域:
- 运动医学 运动医学
- 神经学 神经学
- 内分泌学 在内分泌学.
背景情况:
- 激素避孕药 (HC) 和月经周期阶段可能会影响脑震荡症状的严重程度和恢复.
- 假设荷尔蒙因素可以解释脑震荡评估结果的基于性别的差异.
- HC使用对基线脑震荡症状的影响,包括症状报告和挑,仍未得到充分探索.
研究的目的:
- 调查荷尔蒙避孕药 (HC) 使用对基线症状报告和大学年龄人群前庭/眼部运动查的影响.
主要方法:
- 一项横截面研究包括61名参与者:21名使用HC的女性,21名不使用HC的女性和19名男性.
- 参与者完成了基线症状评估,包括脑震荡后症状量表 (PCSS),头痛影响测试-6 (HIT-6),儿科静脉症状问卷 (PVSQ) 和静脉/眼动力查 (VOMS).
- 结果措施集中在PCSS症状报告,HIT-6和PVSQ得分以及VOMS症状诱发.
主要成果:
- 与非HC用户相比,HC用户在HIT-6 (头痛),PVSQ (头,不稳定) 和PCSS (总症状,严重程度,前庭体质,认知感官,睡眠唤醒,情感因素) 上的得分显著更高.
- 与非HC用户相比,HC组在VOMS的顺追踪项目上表现出更大的症状诱发.
- 男性报告的症状较少,挑较少,比HC使用和非HC使用的女性要少.
结论:
- 荷尔蒙避孕药的使用与更大的整体症状和自我报告的症状有关于前体相关的措施和脑震荡尺度.
- 与非使用者和男性对照者相比,HC使用者表现出增加的前庭/眼部运动查挑,特别是在平滑的追逐中.
- 研究结果表明,HC使用是脑震荡症状和评估的一个重要因素,可能会影响受伤结果的性别差异.
相关概念视频
Equilibrium and Balance
4.6K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
4.6K
The Vestibular System
39.5K
The vestibular system is a set of inner ear structures that provide a sense of balance and spatial orientation. This system is comprised of structures within the labyrinth of the inner ear, including the cochlea and two otolith organs—the utricle and saccule. The labyrinth also contains three semicircular canals—superior, posterior, and horizontal—that are oriented on different planes.
39.5K
Hormonal Regulation of the Menstrual Cycle
320
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
320
Hormonal Control of the Ovarian Cycle
451
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
451
Disorders of the Female Reproductive System
338
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
338
Pathophysiology of Vomiting
348
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
348


